LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2017
At a glance
- Drugs LEO 32731 (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Proof of concept; Therapeutic Use
- Sponsors LEO Pharma
- 25 Aug 2017 Status changed from active, no longer recruiting to completed.
- 14 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Sep 2016 Status changed from not yet recruiting to recruiting.